Revolutionary Cancer Treatment: How Engineered Viruses Could Transform Genetic Medicine Delivery
Stock Titanarrow_outwardCalidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
Yahoo Financearrow_outwardBreaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
PR Newswire UKarrow_outwardCalidi Biotherapeutics Stock Jumps 39% After Hours โ What's Going On - Benzinga
Benzingaarrow_outwardCalidi Biotherapeutics (NYSE:CLDI) Shares Up 5.6% โ Still a Buy? - Defense World
Defense Worldarrow_outwardCertain Common Stock of Calidi Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener
MarketScreenerarrow_outwardCLDI stock touches 52-week low at $0.35 amid market challenges - Investing.com
Investing.comarrow_outwardCLDI stock touches 52-week low at $0.35 amid market challenges - Investing.com Canada
Investing.com Canadaarrow_outwardCalidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewswire
GlobeNewswirearrow_outwardCalidi Biotherapeutics Reports 2024 Financial Results and Progress - TipRanks
TipRanksarrow_outwardCalidi Biotherapeutics Faces Market Turmoil: Is Recovery On The Horizon? - timothysykes.com
Timothysykes.comarrow_outwardCalidi Biotherapeutics (NYSE American: CLDI) to Present Antitumor Virotherapy Platform Data at Conferences - Barchart.com
Barchart.comarrow_outwardNYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times
The Manila Timesarrow_outwardUpcoming Stock Splits This Week (July 15 to July 19) โ Stay Invested - Nasdaq
Nasdaqarrow_outwardWhy Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today? - InvestorPlace
InvestorPlacearrow_outwardCLDI Stock Price and Chart โ AMEX:CLDI - TradingView
TradingViewarrow_outward
Cldi Stock close
- 2025-07-09 20:30 event
- 16 sourceslanguage
- 200+ ads_click
- 3 days ago schedule